These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29984593)

  • 1. Differentiation of Type 1 and Type 2 Myocardial Infarctions Among HIV-Infected Patients Requires Adjudication Due to Overlap in Risk Factors.
    Nance RM; Crane HM; Ritchings C; Rosenblatt L; Budoff M; Heckbert SR; Drozd DR; Mathews WC; Geng E; Hunt PW; Feinstein MJ; Moore RD; Hsue P; Eron JJ; Burkholder GA; Rodriguez B; Mugavero MJ; Saag MS; Kitahata MM; Delaney JAC
    AIDS Res Hum Retroviruses; 2018 Nov; 34(11):916-921. PubMed ID: 29984593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality following myocardial infarction among HIV-infected persons: the Center for AIDS Research Network Of Integrated Clinical Systems (CNICS).
    Feinstein MJ; Nance RM; Delaney JAC; Heckbert SR; Budoff MJ; Drozd DR; Burkholder GA; Willig JH; Mugavero MJ; Mathews WC; Moore RD; Eron JJ; Napravnik S; Hunt PW; Geng E; Hsue P; Peter I; Lober WB; Crothers K; Grunfeld C; Saag MS; Kitahata MM; Lloyd-Jones DM; Crane HM
    BMC Med; 2019 Jul; 17(1):149. PubMed ID: 31362721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brief Report: Differences in Types of Myocardial Infarctions Among People Aging With HIV.
    Crane HM; Nance RM; Whitney BM; Heckbert SR; Budoff M; High K; Landay A; Feinstein M; Moore RD; Mathews WC; Christopoulos K; Saag MS; Willig A; Eron JJ; Kitahata MM; Delaney JAC;
    J Acquir Immune Defic Syndr; 2021 Feb; 86(2):208-212. PubMed ID: 33433123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between alcohol and cigarette use and type 1 and 2 myocardial infarction among people with HIV.
    Drumright LN; Nance RM; Ruderman SA; Ma J; Whitney BM; Hahn A; Fredericksen RJ; Luu B; Lober WB; Moore RD; Budoff MJ; Keruly JC; Christopoulos K; Puryear S; Willig A; Cropsey K; Mathews WC; Cachay E; Bamford L; Eron JJ; Napravnik S; Mayer KH; O'Cleirigh C; Mccaul ME; Chander G; Feinstein MJ; Saag MS; Kitahata MM; Heckbert SR; Crane HM; Delaney JAC
    HIV Med; 2023 Jun; 24(6):703-715. PubMed ID: 36855253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Bilirubin, Atazanavir, and Cardiovascular Disease Events Among People Living With HIV Across the United States.
    Crane HM; Nance RM; Heckbert SR; Ritchings C; Rosenblatt L; Budoff M; Wood BR; Tirschwell DL; Kim HN; Mathews WC; Geng E; Moore RD; Hunt PW; Eron JJ; Burkholder GA; Drozd DR; Chow FC; Becker KJ; Zunt JR; Ho EL; Kalani R; Huffer A; Whitney BM; Saag MS; Kitahata MM; Delaney JAC
    J Acquir Immune Defic Syndr; 2019 Aug; 81(5):e141-e147. PubMed ID: 31135582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Chronic Hepatitis C Virus Infection and Myocardial Infarction Among People Living With HIV in the United States.
    Williams-Nguyen J; Hawes SE; Nance RM; Lindström S; Heckbert SR; Kim HN; Mathews WC; Cachay ER; Budoff M; Hurt CB; Hunt PW; Geng E; Moore RD; Mugavero MJ; Peter I; Kitahata MM; Saag MS; Crane HM; Delaney JA
    Am J Epidemiol; 2020 Jun; 189(6):554-563. PubMed ID: 31712804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polygenic risk scores point toward potential genetic mechanisms of type 2 myocardial infarction in people with HIV.
    Lee WJ; Cheng H; Whitney BM; Nance RM; Britton SR; Jordahl K; Lindstrom S; Ruderman SA; Kitahata MM; Saag MS; Willig AL; Burkholder G; Eron JJ; Kovacic JC; Björkegren JLM; Mathews WC; Cachay E; Feinstein MJ; Budoff M; Hunt PW; Moore RD; Keruly J; McCaul ME; Chander G; Webel A; Mayer KH; Delaney JA; Crane PK; Martinez C; Crane HM; Hao K; Peter I
    Int J Cardiol; 2023 Jul; 383():15-23. PubMed ID: 37149004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Types of Myocardial Infarction Among Human Immunodeficiency Virus-Infected Individuals in the United States.
    Crane HM; Paramsothy P; Drozd DR; Nance RM; Delaney JA; Heckbert SR; Budoff MJ; Burkholder GA; Willig JH; Mugavero MJ; Mathews WC; Crane PK; Moore RD; Eron JJ; Napravnik S; Hunt PW; Geng E; Hsue P; Rodriguez C; Peter I; Barnes GS; McReynolds J; Lober WB; Crothers K; Feinstein MJ; Grunfeld C; Saag MS; Kitahata MM;
    JAMA Cardiol; 2017 Mar; 2(3):260-267. PubMed ID: 28052152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence, Trends, and Outcomes of Type 2 Myocardial Infarction in a Community Cohort.
    Raphael CE; Roger VL; Sandoval Y; Singh M; Bell M; Lerman A; Rihal CS; Gersh BJ; Lewis B; Lennon RJ; Jaffe AS; Gulati R
    Circulation; 2020 Feb; 141(6):454-463. PubMed ID: 31902228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discordance between ICD-Coded Myocardial Infarction and Diagnosis according to the Universal Definition of Myocardial Infarction.
    Díaz-Garzón J; Sandoval Y; Smith SW; Love S; Schulz K; Thordsen SE; Johnson BK; Driver B; Jacoby K; Carlson MD; Dodd KW; Moore J; Scott NL; Bruen CA; Hatch R; Apple FS
    Clin Chem; 2017 Jan; 63(1):415-419. PubMed ID: 27811209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and occurrence of type 2 myocardial infarction in emergency department patients: a prospective study.
    Greenslade JH; Adikari T; Mueller C; Sandoval Y; Nestelberger T; Parsonage W; Hawkins T; Cullen L
    Emerg Med J; 2018 Mar; 35(3):169-175. PubMed ID: 28784608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic obstructive pulmonary disease and the risk for myocardial infarction by type in people with HIV.
    Crothers K; Nance RM; Whitney BM; Harding BN; Heckbert SR; Budoff MJ; Mathews WC; Bamford L; Cachay ER; Eron JJ; Napravnik S; Moore RD; Keruly JC; Willig A; Burkholder G; Feinstein MJ; Saag MS; Kitahata MM; Crane HM; Delaney JAC;
    AIDS; 2023 Apr; 37(5):745-752. PubMed ID: 36728918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Abacavir Use Increases Risk of Type 1 and Type 2 Myocardial Infarctions Among Adults With HIV.
    Elion RA; Althoff KN; Zhang J; Moore RD; Gange SJ; Kitahata MM; Crane HM; Drozd DR; Stein JH; Klein MB; Eron JJ; Silverberg MJ; Mathews WC; Justice AC; Sterling TR; Rabkin CS; Mayor AM; Klein DB; Horberg MA; Bosch RJ; Eyawo O; Palella FJ;
    J Acquir Immune Defic Syndr; 2018 May; 78(1):62-72. PubMed ID: 29419568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 2 myocardial infarction: A descriptive analysis and comparison with type 1 myocardial infarction.
    Landes U; Bental T; Orvin K; Vaknin-Assa H; Rechavia E; Iakobishvili Z; Lev E; Assali A; Kornowski R
    J Cardiol; 2016 Jan; 67(1):51-6. PubMed ID: 25956551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of type 1 and type 2 myocardial infarction using a high-sensitivity cardiac troponin I assay with sex-specific 99th percentiles based on the third universal definition of myocardial infarction classification system.
    Sandoval Y; Smith SW; Schulz KM; Murakami MM; Love SA; Nicholson J; Apple FS
    Clin Chem; 2015 Apr; 61(4):657-63. PubMed ID: 25672334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Six-month cardiovascular prognostic impact of type 1 And type 2 myocardial infarction in patients hospitalized for gastrointestinal bleeding.
    Pemmasani G; Ashwath A; Aronow WS; Yandrapalli S; Leighton J; John S
    Eur J Intern Med; 2023 Oct; 116():51-57. PubMed ID: 37500309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction.
    Horiuchi Y; Wettersten N; Patel MP; Mueller C; Neath SX; Christenson RH; Morgenthaler NG; McCord J; Nowak RM; Vilke GM; Daniels LB; Hollander JE; Apple FS; Cannon CM; Nagurney JT; Schreiber D; deFilippi C; Hogan C; Diercks DB; Headden G; Limkakeng AT; Anand I; Wu AHB; Ebmeyer S; Jaffe AS; Peacock WF; Maisel A
    Circulation; 2020 Oct; 142(16):1532-1544. PubMed ID: 32820656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct comparison of high-sensitivity cardiac troponin T and I in the early differentiation of type 1 vs. type 2 myocardial infarction.
    Nestelberger T; Boeddinghaus J; Giménez MR; Lopez-Ayala P; Ratmann PD; Badertscher P; Wildi K; Wussler D; Koechlin L; Arslani K; Zimmermann T; Freese M; Rinderknecht T; Miró Ò; Martin-Sanchez FJ; Kawecki D; Geigy N; Keller D; Twerenbold R; Müller C;
    Eur Heart J Acute Cardiovasc Care; 2022 Jan; 11(1):62-74. PubMed ID: 34195803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copeptin for the differentiation of type 1 versus type 2 myocardial infarction or myocardial injury.
    Kassem M; Ayala PL; Andric-Cancarevic T; Tajsic M; Vargas KG; Bendik D; Kaufmann C; Wojta J; Mueller C; Huber K
    Int J Cardiol; 2024 May; 403():131879. PubMed ID: 38369132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incident Type 2 Myocardial Infarction in a Cohort of Patients Undergoing Coronary or Peripheral Arterial Angiography.
    Gaggin HK; Liu Y; Lyass A; van Kimmenade RR; Motiwala SR; Kelly NP; Mallick A; Gandhi PU; Ibrahim NE; Simon ML; Bhardwaj A; Belcher AM; Harisiades JE; Massaro JM; D'Agostino RB; Januzzi JL
    Circulation; 2017 Jan; 135(2):116-127. PubMed ID: 27881568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.